R3 STEM CELL
LIVE

Serial Number

99847188

Owner

Greene Technologies, LLC

Attorney

Marc Cullen Goldsen

First Use Date

Feb 18, 2014

Filing Date

May 26, 2026

Add to watchlist:

No watchlists yet
View on USPTO

R3 STEM CELL Trademark

Serial Number: 99847188

R3 STEM CELL is a trademark filed by Greene Technologies, LLC on May 26, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Greene Technologies, LLC (5 trademarks)

6042 E. Brianna Rd.
Cave Creek, AZ 85331

Entity Type: 16

Trademark Details

Filing Date

May 26, 2026

Registration Date

Not Registered

First Use Anywhere

February 18, 2014

First Use in Commerce

March 1, 2014

Goods & Services

Health care; Medical analysis for the diagnosis and treatment of persons; Medical diagnosis and treatment of Achilles tears, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, ankle sprains, arthritis, autism, autoimmune diseases such as rheumatoid arthritis (RA), lupus and psoriasis, back pain, cardiomyopathy, carpal tunnel syndrome, cartilage defects, chronic obstructive pulmonary disease (COPD), Complex Regional Pain Syndrome (CRPS), degenerative disc disease, diabetes, erectile dysfunction (ED), facet syndrome, failed back surgery syndrome (FBSS), fractures, headaches and heart failure; Medical diagnosis and treatment of interstitial cystitis, kidney failure, knee ligament injuries, lichen sclerosus, Lyme disease, migraines, multiple sclerosis (MS), neck pain, neuropathy, Parkinson's disease, pelvic pain, phantom limb pain, plantar fasciitis, postherpetic neuralgia, post-laminectomy syndrome, pudendal neuralgia, reflex sympathetic dystrophy (RSD), rotator cuff tears, sacroiliac (SI) joint pain, sciatica, spinal stenosis, stroke, tendonitis, tension headaches and trigeminal neuralgia; Health center services; Health clinic services; Regenerative medicine services; Stem cell therapy services

Medical and scientific research in the field of regenerative medicine; Medical and scientific research, namely, conducting clinical trials for others; Biological research and analysis; Stem cell research services; Scientific laboratory services

Business management assistance; Business management consultancy; Consultancy regarding advertising communication strategies; Consultancy regarding public relations communication strategies; Dissemination of advertising matter; Distribution of prospectuses and samples; Market intelligence services; Sales promotion for others; Professional business consultancy; Business management consulting, strategic planning and business advisory services provided to connect regenerative medicine treatment providers with patients and clients and to connect patients and clients with regenerative medicine treatment providers

Filing History

APPLICATION FILING RECEIPT MAILED
May 26, 2026 MAFR
NEW APPLICATION ENTERED
May 26, 2026 NWAP